PEPVac

CER Groupe Coordinator: Patrice Filée

The PEPVAC project aims to establish an integrated preclinical platform combining in vitro, in vivo, and ex vivo tools to assess the safety, tolerability, and efficacy of vaccine candidates and passive immunotherapy solutions. Led by the IMI (ULB) and CER Groupe, it strengthens regional capacities in immunomonitoring and bioproduction, while aligning with a strategy to reduce animal use and to promote local expertise within the industrial sector.

This project is carried out with the financial support of the European Union.